Go Pro
LON:CSRT

Consort Medical plc (CSRT.L) (CSRT) Share Price, News & Analysis

Consort Medical plc (CSRT.L) logo

About Consort Medical plc (CSRT.L) Stock (LON:CSRT)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
768 shs
Average Volume
520,697 shs
Market Capitalization
£504.60 million
P/E Ratio
127.85
Dividend Yield
2.75%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.

Receive CSRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Consort Medical plc (CSRT.L) and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CSRT Stock News Headlines

MD Medical Group Investments PLC DR
Medical Guardian Mini Guardian Review
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
FAMDF Futura Medical plc
KETL.L - Strix Group Plc
SAFE.L - Safestore Holdings plc
EDX Medical Group PLC Ordinary Shares
See More Headlines

CSRT Stock Analysis - Frequently Asked Questions

Shares of CSRT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Consort Medical plc (CSRT.L) investors own include Chubb (CB), Petrel Resources (PET), Atco Mining (ATMGF), Barrick Gold (ABX), Bank of Ireland Group (BKRIY) and

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Medical Appliances & Equipment
Sub-Industry
N/A
Current Symbol
LON:CSRT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
127.85
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
55.58
Current Ratio
1.83
Quick Ratio
1.16

Sales & Book Value

Annual Sales
£298.60 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
33.44
Book Value
GBX 465.50 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
49,960,600
Free Float
N/A
Market Cap
£504.60 million
Optionable
Not Optionable
Beta
N/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:CSRT) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners